Date: October 12, 2018 What is an advisory committee? Advisory committees provide independent expert advice to the FDA on broad scientific topics or on certain products […]

Presentation  Speaker  Welcome  and  Data Quality: Why Do We Care?   David Burrow, PharmD, JD   Director  Office of Scientific Integrity, Office of Compliance, CDER  Robert J. Temple, MD  Deputy […]

On This Page Date: October 18, 2018 What is an advisory committee? Advisory committees provide independent expert advice to the FDA on broad scientific topics or […]

Login, complete evaluation, and print certificate Navigate to https://ceportal.fda.gov/ If you have an account, please login If you do not have an account, click on “Create […]

Login, complete evaluation, and print certificate Navigate to https://ceportal.fda.gov/ If you have an account, please login If you do not have an account, click on “Create […]

FDA’s Drug Supply Chain Security Act (DSCSA) Pilot Project Program was established to assist drug supply chain stakeholders, including FDA, with developing electronic, interoperable capabilities that […]

On March 6, 2024, the Food and Drug Administration approved nivolumab (Opdivo, Bristol-Myers Squibb Company) in combination with cisplatin and gemcitabine for first-line treatment of adult […]